ID: ALA226312

Max Phase: Preclinical

Molecular Formula: C13H15ClN4O3

Molecular Weight: 310.74

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1nc(N)c(-c2ccc(Cl)cc2)c([C@H](O)[C@H](O)CO)n1

Standard InChI:  InChI=1S/C13H15ClN4O3/c14-7-3-1-6(2-4-7)9-10(11(21)8(20)5-19)17-13(16)18-12(9)15/h1-4,8,11,19-21H,5H2,(H4,15,16,17,18)/t8-,11-/m1/s1

Standard InChI Key:  ZKJHTTIOFWOKOG-LDYMZIIASA-N

Associated Targets(Human)

Dihydrofolate reductase 3072 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Dihydrofolate reductase 79 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dihydrofolate reductase 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 310.74Molecular Weight (Monoisotopic): 310.0833AlogP: 0.35#Rotatable Bonds: 4
Polar Surface Area: 138.51Molecular Species: NEUTRALHBA: 7HBD: 5
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 7#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.69CX Basic pKa: 6.65CX LogP: 0.12CX LogD: 0.05
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.55Np Likeness Score: 0.02

References

1. El-Hamamsy MH, Smith AW, Thompson AS, Threadgill MD..  (2007)  Structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium tuberculosis.,  15  (13): [PMID:17451962] [10.1016/j.bmc.2007.04.011]

Source